MedTrace Logo

An Evaluation of Healthcare Providers' Adherence to Pharmacovigilance Practices in an African Community

NCT06428162 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-08-07

No results posted yet for this study

Summary

Egypt's several regions-rural, mixed, and urban-were given pre-designed surveys pertaining to drug adverse events and the role of pharmacovigilance in detection and reporting. The three sections of the survey were dedicated to studying health care professionals' knowledge concerning pharmacovigilance concepts and practices, as well as demographics and people reported or not reported. The survey also asked more questions regarding adverse occurrences that were reported.

Conditions

  • Drug Reaction
  • Drug Hypersensitivity
  • Drug Abuse
  • Drug Interaction

Interventions

OTHER

questionner

three sections questioner including: demographics, reported cases, unreported cases

Sponsors & Collaborators

  • Deraya University

    lead OTHER

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-18
Primary Completion
2024-05-20
Completion
2024-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06428162 on ClinicalTrials.gov